Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model

Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1062-5. doi: 10.1007/BF01984930.

Abstract

A dynamic in vitro model was used to determine the killing kinetics of daptomycin against 15 vancomycin-resistant clinical isolates of Enterococcus faecium. Concentration profiles simulating those observed in serum following administration of both low-dose (2 mg/kg) and high-dose (6 mg/kg) daptomycin were bactericidal within 5.5 and 2.8 h, respectively. In contrast, when albumin was added to the growth medium, the corresponding bacterial killing times were slowed to greater than 24 h and 7 h; these results suggest that in the clinical setting, daptomycin dosages of approximately 6 mg/kg are required to achieve bactericidal activity against vancomycin-resistant Enterococcus faecium.

MeSH terms

  • Albumins / pharmacology
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / pharmacology*
  • Daptomycin
  • Dose-Response Relationship, Drug
  • Drug Resistance, Microbial
  • Enterococcus faecium / drug effects*
  • Microbial Sensitivity Tests
  • Models, Biological
  • Peptides / blood
  • Peptides / pharmacology
  • Serum Bactericidal Test
  • Vancomycin / blood
  • Vancomycin / pharmacology*

Substances

  • Albumins
  • Anti-Bacterial Agents
  • Peptides
  • Vancomycin
  • Daptomycin